Related Experiment Video

Updated: Sep 27, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Regulation of matrix metalloprotease activity in malignant mesothelioma cell lines by growth factors

Z Liu1, J Klominek

  • 1Division of Clinical Immunology and Division of Respiratory Medicine and Allergology, Karolinska Institute at Huddinge University Hospital, S-141 86 Stockholm, Sweden.

Thorax
|March 4, 2003
PubMed
Abstract

Insights

Growth factors significantly regulate matrix metalloproteinases (MMPs) in malignant mesothelioma cells, impacting tumor invasion. This study reveals broad growth factor control over MMP-9 and MMP-3 production.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Malignant mesothelioma is an aggressive cancer.
  • Extracellular matrix metalloproteinases (MMPs) are crucial for tumor invasion and metastasis.
  • Malignant mesothelioma cells express several MMPs, but their regulation is poorly understood.

Purpose of the Study:

  • To investigate the regulation of MMP-2, -3, and -9 expression in malignant mesothelioma cells.
  • To determine the effects of various growth factors on MMP secretion.
  • To examine the role of growth factor receptors in this process.

Main Methods:

  • Substrate zymography was used to assess MMP secretion.
  • Reverse transcription-polymerase chain reaction (RT-PCR) was employed to detect growth factor receptor expression.
  • The effects of specific growth factors and a tyrosine kinase inhibitor were analyzed.

Main Results:

  • Multiple growth factors, including EGF and its ligands, significantly increased MMP-9 and/or MMP-3 secretion.
  • MMP-2 production remained unaffected by the tested growth factors.
  • Genistein, a tyrosine kinase inhibitor, suppressed growth factor-induced MMP production.

Conclusions:

  • Growth factors broadly regulate MMPs in malignant mesothelioma cells.
  • This regulation involves growth factor receptors and tyrosine kinase signaling pathways.
  • Findings provide insights into potential therapeutic targets for mesothelioma.

More Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...